Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sanofi Includes OTCs As Key Touchstone On Growth Chart

This article was originally published in The Tan Sheet

Executive Summary

Sanofi-Aventis' planned dedicated OTC division will be a key component in the firm's efforts to better focus on maximizing product opportunities and identifying new acquisition targets
Advertisement

Related Content

Sanofi Builds OTC Business Through Organic Growth And Bolt-Ons
Sanofi Builds OTC Business Through Organic Growth And Bolt-Ons
Sanofi Builds OTC Business Through Organic Growth And Bolt-Ons
Open Russian OTC Market Would Come With Challenges
Open Russian OTC Market Would Come With Challenges
Open Russian OTC Market Would Come With Challenges
Sanofi-Aventis Acquisitions Could Double OTC Sales By 2014
Sanofi-Aventis Acquisitions Could Double OTC Sales By 2014

Topics

Advertisement
UsernamePublicRestriction

Register

PS103192

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel